When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALLO - Allogene Therapeutics EPS beats by $0.02 misses on revenue
Allogene Therapeutics Inc.
Allogene Therapeutics (NASDAQ:ALLO): Q2 GAAP EPS of -$0.53 beats by $0.02. Revenue of $0.04M. The Company had $913.2M in cash, cash equivalents, and investments as of June 30, 2021. Allogene continues to expect FY GAAP Operating Expenses to be between $300 and $330M including estimated non-cash stock-based compensation expense of $80 to $90M and excluding any impact from potential new business development activities. Press Release